Opko Health (OPK) could reach $2.50 with enough support
Opko Health (OPK) currently trades at $1.30 and has fallen by 3.33% today. Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. It has a development and commercial supply pharmaceutical company, global supply-chain operation and holding company and a specialty active pharmaceutical ingredients manufacturer in Israel. JP Morgan analyst stated in their research note that they expect to see OPK stock at the price of $2.50. The rating they have provided for OPK stocks is “Underweight” according to the report published on March 2, 2018.
Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating based on current information written in this article. The high forecast for Opko Health is $6.00 and the low is $3.00. Notably, the company’s market cap is $874.13 million with a 52 week high of $2.91 and a 52 week low of $1.12. OPK went down $0.04 from the previous closing price of $1.35. OPK has changed in price by -1.22 per share in the last 12 months.